1
Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Condition(s): Peripheral T-cell Lymphoma Last Updated: May 8, 2013Completed
12 Clinical Trials for: “10-deazaaminopterin”, Page 1 of 1
Hide Studies Not Seeking New Volunteers
2
10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific Last Updated: February 6, 2009Completed
3
10-Propargyl-10-Deazaaminopterin in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Condition(s): Lung Cancer Last Updated: December 3, 2009Completed
4
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
Condition(s): Lymphoma Last Updated: December 13, 2009Completed
5
Study of Pralatrexate vs. Erlotinib for Non-Small Cell Lung Cancer After at Least 1 Prior Platinum-based Treatment
Condition(s): Non-small Cell Lung Cancer Last Updated: May 8, 2013Completed
6
Study of Pralatrexate in Female Patients With Previously-treated Breast Cancer
Condition(s): Breast Cancer; Breast Tumors; Neoplasms, Breast; Cancer of the Breast; Human Mammary Carcinoma Last Updated: May 8, 2013Completed
7
Study of Pralatrexate in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Condition(s): Cutaneous T-cell Lymphoma Last Updated: May 8, 2013Completed
8
Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma
Condition(s): Cutaneous T-cell Lymphoma; Mycosis Fungoides; Sezary Syndrome; Primary Cutaneous Anaplastic Large Cell Lymphoma Last Updated: May 8, 2013Active, not recruiting
9
Study of Pralatrexate to Treat Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma
Condition(s): Lymphoma, B-Cell Last Updated: May 8, 2013Active, not recruiting
10
Study of Pralatrexate to Treat Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder
Condition(s): Carcinoma, Transitional Cell; Bladder Cancer; Bladder Neoplasm Last Updated: May 8, 2013Completed
11
Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies
Condition(s): Relapsed or Refractory Lymphoproliferative Malignancies; Hodgkin's Lymphoma; Peripheral T-cell Lymphoma; B-cell Lymphoma; Waldenstrom's Macroglobulinemia Last Updated: May 8, 2013Completed
12
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Condition(s): Peripheral T-cell Lymphoma Last Updated: May 8, 2013Recruiting
